{"date":"2026-05-11","count":66,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6827-2026-05-11-2143-1uqqdhk","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"21:43:44","subject":"公告本公司董事會決議召開115年股東會常會相關事宜(增列召集事由)-配合電子投票系統，刪除增列事項","clause":"第32款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-05-11 21:43，「公告本公司董事會決議召開115年股東會常會相關事宜(增列召集事由)-配合電子投票系統，刪除增列事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-05-11-2102-ya30ul","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"21:02:13","subject":"公告本公司董事會決議通過115年第1季合併財務報告","clause":"第31款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-05-11 21:02，「公告本公司董事會決議通過115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-05-11-2059-uvms4v","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"20:59:22","subject":"公告本公司董事會決議通過財務主管、會計主管、公司治理主管及代理發言人任命案","clause":"第8款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-05-11 20:59，「公告本公司董事會決議通過財務主管、會計主管、公司治理主管及代理發言人任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-05-11-1954-uo9i76","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"19:54:30","subject":"公告董事會決議通過增資新加坡子公司Lotus International Pte. Ltd.","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-05-11 19:54，「公告董事會決議通過增資新加坡子公司Lotus International Pte. Ltd.」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-05-11-1954-xves6y","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"19:54:16","subject":"本公司處分日本子公司Lotus Japan Holdings Co., Ltd.之100%所有權","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-05-11 19:54，「本公司處分日本子公司Lotus Japan Holdings Co., Ltd.之100%所有權」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-05-11-1953-uapze7","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"19:53:59","subject":"公告本公司董事會決議通過115年第一季財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-05-11 19:53，「公告本公司董事會決議通過115年第一季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2026-05-11-1935-1bcv4sg","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"19:35:05","subject":"公告本公司取得會計師內部控制制度專案審查確信報告","clause":"第25款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-05-11 19:35，「公告本公司取得會計師內部控制制度專案審查確信報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-05-11-1930-1l3azgs","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"19:30:28","subject":"代孫公司United Orthopedic Corporation (Suisse) SA依公開發行公司資金貸與及背書保證處理準則第二十二條第三款公告","clause":"第23款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-05-11 19:30，「代孫公司United Orthopedic Corporation (Suisse) SA依公開發行公司資金貸與及背書保」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-05-11-1928-9h0ctm","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"19:28:16","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-05-11 19:28，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-05-11-1927-isqttc","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"19:27:35","subject":"公告本公司董事會重要決議事項","clause":"第53款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-05-11 19:27，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2026-05-11-1845-9h0ctm","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"18:45:45","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2026-05-11 18:45，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2026-05-11-1844-6gua9l","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"18:44:48","subject":"公告本公司董事會決議召開115年股東常會相關事宜(新增議案)。","clause":"第32款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2026-05-11 18:44，「公告本公司董事會決議召開115年股東常會相關事宜(新增議案)。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-05-11-1838-30di66","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"18:38:38","subject":"代重要子公司太學(江蘇)投資有限公司公告取得太學醫療投資管理(浙江)有限公司股權","clause":"第20款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-05-11 18:38，「代重要子公司太學(江蘇)投資有限公司公告取得太學醫療投資管理(浙江)有限公司股權」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-05-11-1830-9h0ctm","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"18:30:49","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-05-11 18:30，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-05-11-1827-1yzbg1i","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"18:27:19","subject":"公告本公司董事會通過擬向經濟部投審會申請增加對外投資額度美金900萬元，間接投資大陸投資事業","clause":"第20款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-05-11 18:27，「公告本公司董事會通過擬向經濟部投審會申請增加對外投資額度美金900萬元，間接投資大陸投資事業」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2026-05-11-1816-7s6lyr","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"18:16:58","subject":"公告本公司董事會決議通過辦理私募普通股案。","clause":"第9款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2026-05-11 18:16，「公告本公司董事會決議通過辦理私募普通股案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2026-05-11-1804-1roellr","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"18:04:39","subject":"公告本公司董事辭任","clause":"第6款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2026-05-11 18:04，「公告本公司董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-05-11-1736-9h0ctm","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"17:36:23","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-05-11 17:36，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-05-11-1731-v8mmf9","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"17:31:58","subject":"公告本公司董事會通過115年第一季合併財報","clause":"第31款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-05-11 17:31，「公告本公司董事會通過115年第一季合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-05-11-1715-1mwjljt","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"17:15:06","subject":"公告本公司董事會通過115年第一季財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-05-11 17:15，「公告本公司董事會通過115年第一季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-05-11-1710-1g6i233","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"17:10:53","subject":"公告本公司董事長異動","clause":"第6款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-05-11 17:10，「公告本公司董事長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-05-11-1707-9h0ctm","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"17:07:44","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-05-11 17:07，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-05-11-1707-jsrt14","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"17:07:36","subject":"公告本公司董事會通過設置永續發展委員會暨委任委員會成員","clause":"第6款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-05-11 17:07，「公告本公司董事會通過設置永續發展委員會暨委任委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-05-11-1706-13qflv5","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"17:06:11","subject":"依公開發行公司資金貸與及背書保證處理準則相關規定辦理","clause":"第22款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-05-11 17:06，「依公開發行公司資金貸與及背書保證處理準則相關規定辦理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-05-11-1705-c5dfsr","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"17:05:03","subject":"代子公司香港克麗緹娜國際有限公司公告新增轉投資案","clause":"第20款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-05-11 17:05，「代子公司香港克麗緹娜國際有限公司公告新增轉投資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-05-11-1702-y6tzjw","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"17:02:52","subject":"代子公司克麗緹娜（中國）貿易有限公司公告新增轉投資案","clause":"第20款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-05-11 17:02，「代子公司克麗緹娜（中國）貿易有限公司公告新增轉投資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2026-05-11-1702-1qytcve","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"17:02:03","subject":"公告本公司董事會通過對關係人捐贈事宜","clause":"第43款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2026-05-11 17:02，「公告本公司董事會通過對關係人捐贈事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2026-05-11-1701-1wfje4j","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"17:01:33","subject":"本公司115年第1季合併財務報告經提報董事會通過","clause":"第31款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2026-05-11 17:01，「本公司115年第1季合併財務報告經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2026-05-11-1658-pwiw48","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"16:58:11","subject":"公告本公司115年股東常會通過解除現任董事競業禁止之限制","clause":"第21款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2026-05-11 16:58，「公告本公司115年股東常會通過解除現任董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2026-05-11-1657-1jb8ii5","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"16:57:12","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2026-05-11 16:57，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-05-11-1655-1u5afzs","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"16:55:28","subject":"公告本公司董事會決議通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-05-11 16:55，「公告本公司董事會決議通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-05-11-1644-s8rmn8","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"16:44:13","subject":"公告本公司董事會決議通過簽署外泌體技術專屬授權契約之增補協議。","clause":"第53款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-05-11 16:44，「公告本公司董事會決議通過簽署外泌體技術專屬授權契約之增補協議。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-05-11-1643-3mn3s9","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"16:43:33","subject":"本公司董事會通過115年第1季合併財務報告","clause":"第31款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-05-11 16:43，「本公司董事會通過115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-05-11-1636-1pk3403","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"16:36:54","subject":"公告本公司115年4月份自結合併損益","clause":"第53款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-05-11 16:36，「公告本公司115年4月份自結合併損益」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2026-05-11-1633-9h0ctm","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"16:33:33","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：合世（1781），2026-05-11 16:33，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-05-11-1633-fnq1ex","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"16:33:12","subject":"本公司董事會決議115年第一季不分派股利","clause":"第14款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-05-11 16:33，「本公司董事會決議115年第一季不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-05-11-1630-kncmov","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"16:30:06","subject":"公告本公司董事會通過執行長委任案","clause":"第11款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-05-11 16:30，「公告本公司董事會通過執行長委任案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2026-05-11-1627-19b1djy","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"16:27:08","subject":"公告本公司配合會計師事務所內部輪調變更會計師","clause":"第7款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：合世（1781），2026-05-11 16:27，「公告本公司配合會計師事務所內部輪調變更會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-05-11-1627-1f0f4jd","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"16:27:04","subject":"公告本公司115年第1季財務報告董事會召開日期。(補正公告)","clause":"第31款","fact_date":"2026-05-06","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-05-11 16:27，「公告本公司115年第1季財務報告董事會召開日期。(補正公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-05-11-1626-uw1b8v","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"16:26:29","subject":"依據115年05月11日臺中榮民總醫院之決標公告本公司獲得臺中榮民總醫院「單光子電腦斷層掃描儀1式10年租賃案」業務","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-05-11 16:26，「依據115年05月11日臺中榮民總醫院之決標公告本公司獲得臺中榮民總醫院「單光子電腦斷層掃描儀1式10年租賃案」業務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-05-11-1625-1mwjljt","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"16:25:17","subject":"公告本公司董事會通過115年第一季財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-05-11 16:25，「公告本公司董事會通過115年第一季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-05-11-1625-wr0tu2","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"16:25:14","subject":"公告本公司總經理異動","clause":"第11款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-05-11 16:25，「公告本公司總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2026-05-11-1623-gdc7c9","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"16:23:49","subject":"公告本公司董事會通過內部稽核主管異動","clause":"第8款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：合世（1781），2026-05-11 16:23，「公告本公司董事會通過內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-05-11-1622-1kf2x4z","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"16:22:59","subject":"公告本公司任命公司治理主管、資訊安全專責主管","clause":"第8款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-05-11 16:22，「公告本公司任命公司治理主管、資訊安全專責主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-05-11-1622-ya30ul","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"16:22:21","subject":"公告本公司董事會決議通過115年第1季合併財務報告","clause":"第31款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-05-11 16:22，「公告本公司董事會決議通過115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-05-11-1619-1jm43nd","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"16:19:23","subject":"公告本公司取得會計師內部控制專案審查報告","clause":"第25款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-05-11 16:19，「公告本公司取得會計師內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-05-11-1619-1egfkms","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"16:19:09","subject":"公告本公司董事會通過重要決議","clause":"第51款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-05-11 16:19，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-05-11-1609-1dunyy8","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"16:09:21","subject":"公告本公司114年第二期第一次私募普通股訂價相關事宜","clause":"第9款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-05-11 16:09，「公告本公司114年第二期第一次私募普通股訂價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-05-11-1608-m7b5uu","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"16:08:05","subject":"公告本公司第二次買回庫藏股期限屆滿執行情形","clause":"第35款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-05-11 16:08，「公告本公司第二次買回庫藏股期限屆滿執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2026-05-11-1605-p67uuk","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"16:05:57","subject":"公告本公司內部稽核主管異動","clause":"第11款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2026-05-11 16:05，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-05-11-1558-otsdzg","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"15:58:10","subject":"睿生光電114年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-05-11 15:58，「睿生光電114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-05-11-1557-1dchhy7","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"15:57:23","subject":"本公司與Delos Capital 簽署合作協議，雙方擬共同推動相關生物醫藥產品之研究開發與臨床發展","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-05-11 15:57，「本公司與Delos Capital 簽署合作協議，雙方擬共同推動相關生物醫藥產品之研究開發與臨床發展」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-05-11-1527-1vf5upf","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"15:27:50","subject":"代重要子公司育禾管理顧問股份有限公司公告股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-05-11 15:27，「代重要子公司育禾管理顧問股份有限公司公告股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-05-11-1517-16febev","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"15:17:42","subject":"公告本公司董事會通過115年第1季合併財務報告","clause":"第31款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-05-11 15:17，「公告本公司董事會通過115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-05-11-1517-fmubr0","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"15:17:37","subject":"公告本公司董事會決議召開115年股東常會相關事宜(增列召集事項)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-05-11 15:17，「公告本公司董事會決議召開115年股東常會相關事宜(增列召集事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-05-11-1515-r7qijr","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"15:15:01","subject":"公告本公司董事會決議發行115年度限制員工權利新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-05-11 15:15，「公告本公司董事會決議發行115年度限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-05-11-1514-qt746o","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"15:14:10","subject":"公告本公司董事會決議以私募方式辦理現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-05-11 15:14，「公告本公司董事會決議以私募方式辦理現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-05-11-1513-15bgy4q","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"15:13:14","subject":"公告本公司董事會決議不分派股利(新增資本公積彌補虧損)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-05-11 15:13，「公告本公司董事會決議不分派股利(新增資本公積彌補虧損)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-05-11-1511-12wvzfd","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"15:11:44","subject":"公告本公司董事會通過公司章程修改每股面額","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-05-11 15:11，「公告本公司董事會通過公司章程修改每股面額」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-05-11-1439-1wshgwv","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"14:39:41","subject":"公告本公司董事會決議通過解除經理人競業禁止之限制","clause":"第21款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-05-11 14:39，「公告本公司董事會決議通過解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-05-11-1435-ty9ib6","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"14:35:40","subject":"公告本公司向關係人處分使用權資產(提前終止辦公室租約)","clause":"第20款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-05-11 14:35，「公告本公司向關係人處分使用權資產(提前終止辦公室租約)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-05-11-1432-1u5afzs","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"14:32:11","subject":"公告本公司董事會決議通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-05-11 14:32，「公告本公司董事會決議通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-05-11-1430-9idnq","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-05-11","time":"14:30:06","subject":"本公司研發之B10 L-BPA 注射液向台灣衛生福利部食品藥物管理署(TFDA)提出術前輔助治療局部晚期口腔癌之學術研究用人體臨床試驗審查申請(IND)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-05-11 14:30，「本公司研發之B10 L-BPA 注射液向台灣衛生福利部食品藥物管理署(TFDA)提出術前輔助治療局部晚期口腔癌之學術研究」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-05-11-1412-1tfyzhm","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"14:12:55","subject":"公告本公司董事會決議對子公司益興生醫股份有限公司增加投資(事實發生日誤植更正)","clause":"第20款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-05-11 14:12，「公告本公司董事會決議對子公司益興生醫股份有限公司增加投資(事實發生日誤植更正)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-05-11-1127-1fqkmsr","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-05-11","time":"11:27:38","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-05-11 11:27，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-05-11-1116-d25e28","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-05-11","time":"11:16:28","subject":"更正本公司之子公司115年04月資金貸與申報資訊","clause":"第44款","fact_date":"2026-05-11","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-05-11 11:16，「更正本公司之子公司115年04月資金貸與申報資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}